InvestorsHub Logo

greggor62

12/30/09 8:39 AM

#2408 RE: d'anconia #2406

Nice, precise, and to the point. Thanks for the article. I imagine we will have a volatile day w/o news.
Thats part of the trade with all these bio's
good luck if your holding-selling- or buying.
they all seem to be a logical move today. hehehehehehehehehehe

$heff

12/30/09 10:18 AM

#2431 RE: d'anconia #2406

ANX (.355)...the company is taking the NDA filing down to the deadline. A risky move but it could pay off for shareholders or backfire as shareholders get inpatient and sell towards end of the year. High risk/high reward situation here.

Message in reply to:

http://biomedreports.com/articles/most-popular/23113-time-for-adventrx-to-follow-through-on-nda.html